Open AccessCORR Insights®: Which Bone-Modifying Agent is Associated with Better Outcomes in Patients with Metastatic Bone Disease from Lung Cancer? A Systematic Review and Network Meta-Analysis
Author(s) -
Darin Davidson
Publication year - 2021
Publication title -
clinical orthopaedics and related research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.178
H-Index - 204
eISSN - 1528-1132
pISSN - 0009-921X
DOI - 10.1097/corr.0000000000001913
Subject(s) - medicine , denosumab , lung cancer , disease , cancer , bone disease , quality of life (healthcare) , population , oncology , zoledronic acid , radiation therapy , palliative care , surgery , intensive care medicine , osteoporosis , nursing , environmental health